| Landmark Medical Center | |
| 115 Cass Avenue, Woonsocket, Rhode Island 02895 | |
| (401) 769-4100 | |
| Name | Landmark Medical Center |
|---|---|
| Type | Acute Care Hospital |
| Location | 115 Cass Avenue, Woonsocket, Rhode Island |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 410011 |
| NPI Number | 1124143557 |
| Organization Name | APHMFP |
| Address | 115 Cass Ave, Woonsocket, RI 02895 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 401-769-4100 |
News Archive
Recent disease events such as SARS, H1N1 and avian influenza, and haemorrhagic fevers have focussed policy and public concern as never before on epidemics and so-called 'emerging infectious diseases'. Understanding and responding to these often unpredictable events have become major challenges for local, national and international bodies.
AlphaGalileo's international news App keeps you in touch with the latest research news even when you're away from your desk. The App, by default, gives you content that matches your preferences on the desktop site, but you can override these and see all the news from science, applied science, medicine, the arts, humanities, social sciences and business.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Eating a non-calorie restricted Mediterranean diet high in vegetable fats such as olive oil or nuts does not lead to significant weight gain compared to a low-fat diet, according to a large randomised trial published today in The Lancet Diabetes & Endocrinology journal.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 5 days ago
| NPI Number | 1538437942 |
| Organization Name | BLACKSTONE MEDICAL CENTER, INC. |
| Doing Business As | LANDMARK MEDICAL CENTER, INC. |
| Address | 115 Cass Ave, Woonsocket, RI 02895 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 401-769-4100 |
News Archive
Recent disease events such as SARS, H1N1 and avian influenza, and haemorrhagic fevers have focussed policy and public concern as never before on epidemics and so-called 'emerging infectious diseases'. Understanding and responding to these often unpredictable events have become major challenges for local, national and international bodies.
AlphaGalileo's international news App keeps you in touch with the latest research news even when you're away from your desk. The App, by default, gives you content that matches your preferences on the desktop site, but you can override these and see all the news from science, applied science, medicine, the arts, humanities, social sciences and business.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Eating a non-calorie restricted Mediterranean diet high in vegetable fats such as olive oil or nuts does not lead to significant weight gain compared to a low-fat diet, according to a large randomised trial published today in The Lancet Diabetes & Endocrinology journal.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 5 days ago
| NPI Number | 1699752923 |
| Organization Name | PRIME HEALTHCARE SERVICES LANDMARK LLC |
| Doing Business As | LANDMARK MEDICAL CENTER |
| Address | 115 Cass Ave, Woonsocket, RI 02895 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 401-769-4100 |
News Archive
Recent disease events such as SARS, H1N1 and avian influenza, and haemorrhagic fevers have focussed policy and public concern as never before on epidemics and so-called 'emerging infectious diseases'. Understanding and responding to these often unpredictable events have become major challenges for local, national and international bodies.
AlphaGalileo's international news App keeps you in touch with the latest research news even when you're away from your desk. The App, by default, gives you content that matches your preferences on the desktop site, but you can override these and see all the news from science, applied science, medicine, the arts, humanities, social sciences and business.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Eating a non-calorie restricted Mediterranean diet high in vegetable fats such as olive oil or nuts does not lead to significant weight gain compared to a low-fat diet, according to a large randomised trial published today in The Lancet Diabetes & Endocrinology journal.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 5 days ago
| Able to receive lab results electronically | No |
| Able to track patients' lab results, tests, and referrals electronically between visits | No |
News Archive
Recent disease events such as SARS, H1N1 and avian influenza, and haemorrhagic fevers have focussed policy and public concern as never before on epidemics and so-called 'emerging infectious diseases'. Understanding and responding to these often unpredictable events have become major challenges for local, national and international bodies.
AlphaGalileo's international news App keeps you in touch with the latest research news even when you're away from your desk. The App, by default, gives you content that matches your preferences on the desktop site, but you can override these and see all the news from science, applied science, medicine, the arts, humanities, social sciences and business.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Eating a non-calorie restricted Mediterranean diet high in vegetable fats such as olive oil or nuts does not lead to significant weight gain compared to a low-fat diet, according to a large randomised trial published today in The Lancet Diabetes & Endocrinology journal.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 5 days ago
Landmark Medical Center Acute Care Hospital Location: 115 Cass Avenue, Woonsocket, Rhode Island 02895 Phone: (401) 769-4100 |